Kidney International
Издатель: Elsevier · ISSN 0085-2538 · 90 статей
- Hundred years Alport syndrome: a narrative journey through time from discovery to treatment
- B cell-targeting chimeric antigen receptor macrophages protect against autoimmune glomerulonephritis
- The Chronic Renal Insufficiency Cohort (CRIC) study measured hepcidin, cardiovascular, kidney and metabolic outcomes in chronic kidney disease
- Long-term efficacy and safety for the complement factor B inhibitor iptacopan in IgA nephropathy
- Characterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry
- Kidney International: 9 Years of Science, Community, and Change
- Alloimmune risk stratification for kidney transplantation
- Editorial Board
- Subscription Information
- Table of Contents
- in this issue
- Kidney stone disease: to drink or not to drink—that is the question
- journal club
- Off-the-shelf CRISPR-engineered allogeneic human T-cell therapy for tolerance induction in transplantation
- Role of erythroid fibroblast growth factor 23 in regulating erythropoiesis
- Abnormal ER-Golgi vesicular trafficking leads to podocyte detachment
- Gut-targeted interventions to complement PTH-lowering therapy
- Are we ready for the widespread application of transcutaneous measurement of the glomerular filtration rate?
- Fingerprinting the polycystic kidney: radiomics of the noncystic parenchyma for earlier ADPKD detection
- Microvascular inflammation in kidney transplants: finally an effective treatment?
- Estimating GFR: what it is, what it is not, and why prediction cannot settle the question
- The macrophage paradox in renal AL amyloidosis: lessons from histology and imaging
- Fetal growth restriction and lifelong risk of acute kidney injury: advancing the developmental origins of kidney disease
- Hyponatremia treatment guidelines: a necessary course correction
- Slow correction of severe, chronic hyponatremia prevents neurologic complications
- Correcting hyponatremia: how slow should we go?
- Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy
- SEISMIC: a multistakeholder summit addressing access issues in diagnosis and treatment of C3G nephropathy and IC-MPGN
- Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 3: evidence synthesis for guideline development: the KDIGO approach
- Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 4: translating evidence into KDIGO guideline statements